SC 13G
SC 13G
- Company
- Can-Fite BioPharma Ltd.
- Filed
- September 28, 2015
- Accession Number
- 0001193125-15-330874
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →